Soltamox (Rosemont Pharmaceuticals Ltd)
Welcome to the PulseAid listing for the Soltamox drug offered from Rosemont Pharmaceuticals Ltd. This Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rosemont Pharmaceuticals Ltd |
NON-PROPRIETARY NAME: | tamoxifen citrate |
SUBSTANCE NAME: | TAMOXIFEN CITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-10-01 |
END MARKETING DATE: | 0000-00-00 |
Soltamox HUMAN PRESCRIPTION DRUG Details:
Item Description | Soltamox from Rosemont Pharmaceuticals Ltd |
LABELER NAME: | Rosemont Pharmaceuticals Ltd |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/5mL) |
START MARKETING DATE: | 2012-10-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13632-123_653917f0-f878-11e1-a21f-0800200c9a66 |
PRODUCT NDC: | 13632-123 |
APPLICATION NUMBER: | NDA021807 |
Other TAMOXIFEN CITRATE Pharmaceutical Manufacturers / Labelers: